John Longshore, PhD, FACMG, discusses selecting between comprehensive vs single-gene molecular testing in lung cancer.
John W. Longshore, PhD, Carolinas Pathology Group
Advertisement
Articles by John W. Longshore, PhD, Carolinas Pathology Group
John Longshore, PhD, FACMG, discusses key molecular markers in metastatic lung cancer.
Advertisement
Latest Updated Articles
Dr. Longshore on Key Molecular Markers in Metastatic Lung CancerPublished: March 10th 2021 | Updated:
Dr. Longshore on Comprehensive Vs Single-Gene Molecular Testing in Lung CancerPublished: March 22nd 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
The OncFive: Top Oncology Articles for the Week of 1/25
3
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
4
HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts
5